Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
- PMID: 28792382
- PMCID: PMC5621557
- DOI: 10.3201/eid2310.161398
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
Abstract
A woman with extremely drug-resistant tuberculosis treated with a drug regimen including linezolid and bedaquiline during her last 3 weeks of pregnancy gave birth to a child without abnormalities. No fetal toxicities were noted by 2 years after delivery. This drug combination might be safe during the late third trimester of pregnancy.
Keywords: France; Georgia; MDR TB; Mycobacterium tuberculosis; XDR TB; antimicrobial resistance; bacteria; bedaquiline; case study; linezolid; multidrug-resistant tuberculosis; mycobacteria; pregnancy; respiratory infections; tuberculosis.
References
-
- World Health Organization. Global tuberculosis report 2015. Geneva: The Organization; 2015. [cited 2017 Jun 13]. http://www.who.int/tb/publications/global_report/gtbr2015_executive_summ...
-
- World Health Organization. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis, interim policy guidance. Geneva: The Organization; 2013. [cited 2017 Jun 13]. http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf?ua=1 - PubMed
-
- Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, et al.; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort. Clin Infect Dis. 2015;60:188–94. 10.1093/cid/ciu786 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical